Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
Masashi Utsumi(Okayama University), Toshiyoshi Fujiwara(Okayama University), Takeshi Nagasaka(Okayama University), Akinobu Takaki(Okayama University), Kosei Takagi(Okayama Shoka University), Susumu Shinoura(Okayama University), Takashi Kuise(Okayama Red Cross General Hospital), Takahito Yagi(Okayama University), Ryuich Yoshida(Okayama University), Yuzo Umeda(Okayama University), Tomokazu Fuji(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital)
Cited by 12
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178